Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

What Sanofi Early Research Chief Scientist Frank Nestle Is Most Excited About

Jun 22 2022

• By Jessica Merrill

Sanofi — • Source: Shutterstock

Related Content

Sanofi And Amgen Make The Case For OX40 Drugs In Atopic Dermatitis

Oct 04 2021

$1bn Amunix Buy Brings Sanofi Next-Generation TCE Platform

Dec 21 2021

Amgen Expects Quick, Broad Adoption Of Tezspire In Severe Asthma

Dec 20 2021

Sanofi Nabs Kymera IRAK4 Protein Degrader As It Continues To Build In I&I

Jul 09 2020

FDA Sarclisa Approval Marks Sanofi's Reentry Into Oncology

Mar 03 2020

Regeneron Takes Full Libtayo Rights As March Into Oncology Progresses

Jun 02 2022

Nektar/BMS Deal Takes Second Gut Punch As IL-2/PD-1 Combo Goes Down In Flames

Apr 15 2022

Ablynx, Bioverativ Buys Drive Sanofi's Hematology Reign

Jan 29 2018

Sanofi Ready To Pull The Plug On Regeneron 'Life Support'

Sep 19 2017

Related Companies

Sanofi

Regeneron Pharmaceuticals, Inc.

Ablynx N.V.

Nurix Therapeutics, Inc.

IGM Biosciences, Inc.

Seagen Inc.

Amunix Pharmaceuticals, Inc.

AstraZeneca PLC

Kymab Ltd.

Bristol Myers Squibb Company

Synthorx, Inc.

Tidal Therapeutics

Additional Topics

New Science Leadership Research & Development Innovation Platform Technologies Business Strategies Companies BioPharmaceutical

More from New Science

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window